Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06837662 · ClinicalTrials.gov registry record · NA
The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care
A NA study of Opioid Dependence and Substance Abuse Disorders, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06837662: Recruiting NA study of Opioid Dependence and Substance Abuse Disorders, sponsored by Oregon Health and Science University.
NCT06837662 is a NA study of Opioid Dependence and Substance Abuse Disorders that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 70 participants, below the 156-participant average among 29 other Opioid Dependence trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06837662, a NA study of Opioid Dependence and Substance Abuse Disorders, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot clinical trial is to learn if a community informed designed program of addiction counseling with coordinated community peer navigator for people with Opioid Use Disorder (OUD) and other medical conditions can improve engagement in primary care and retention on buprenorphine. The main questions it aims to answer are: * Does the addition of a counseling and peer referral interventions in addition to usual primary care with low-threshold buprenorphine increase retention on medications for opioid use disorder? * Does the addition of counseling and peer referral intervention in addition to usual primary care with low-threshold buprenorphine increase engagement in primary care? Researchers will compare the MOUD "Plus" intervention compared to primary care treatment as usual low-threshold buprenorphine prescribing practice to see if MOUD "Plus" improves retention and engagement. Participants will upon screening and enrollment: * Meet with prescribers who will determine dose of buprenorphine and assess other medical issues as per treatment as usual with visits every 2-4 weeks * Meet with the integrated addictions counselor to develop rapport and support around clinic engagement, brief counseling intervention, and coordination of care in support of their MOUD * Be referred to a community based peer who meets with participants outside the clinic for support and advocacy for patient directed recovery goals * Meet with the research coordinator at 2, 3, and 6 months to complete follow-up surveys about their care and experiences
Primary Outcome
Retention is defined as a composite measure assessed at follow-up on whether they report being prescribed and taking MOUD, and how days since the last follow-up they have been on MOUD, confirmed by chart review.
Conditions Studied
Interventions
- BEHAVIORAL MOUD "Plus" Intervention (treatment as usual + coordinated counseling and referral to community based peer)
- BEHAVIORAL Treatment As Usual (primary care with low threshold MOUD prescribing)
Study Locations (1)
Oregon
- Central City Concern - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-03-24 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT06837662 shows while recruiting
NCT06837662 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 156-participant average among 29 other Opioid Dependence trials with a reported enrollment target (55% lower).
The record links to 4 conditions, with Opioid Dependence appearing as the primary indexed condition, and to 2 interventions - of which MOUD "Plus" Intervention (treatment as usual + coordinated counseling and referral to community based peer) is the first listed.
NCT06837662 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT06837662 about?
NCT06837662 is a clinical study titled "The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care". The goal of this pilot clinical trial is to learn if a community informed designed program of addiction counseling with coordinated community peer navigator for people with Opioid Use Disorder (OUD) and other medical conditions can improve engagement in primary care and retention on buprenorphine. ...
What is the current status of trial NCT06837662?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-03-24. Estimated completion is 2026-12-01.
What conditions does trial NCT06837662 study?
This clinical trial studies the following conditions: Opioid Dependence, Substance Abuse Disorders, Complex Medical Patients, Primary Care Patients With Chronic Conditions.
What interventions are being tested in trial NCT06837662?
The interventions under investigation include: MOUD "Plus" Intervention (treatment as usual + coordinated counseling and referral to community based peer) (BEHAVIORAL), Treatment As Usual (primary care with low threshold MOUD prescribing) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06837662?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06837662 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06837662's enrollment target sits among peer trials
70 18th of 29 higher than 12 of 29 other Opioid Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation and Cognitive Training in Opioid Use Disorder
RECRUITING · NA
-
Intervening With Opioid-Dependent MothersMothers and Infants
RECRUITING · NA
-
Comparing Home, Office, and Telehealth Induction for Medication Assisted Treatment for Opioid Use Disorder
ACTIVE NOT RECRUITING · NA
-
Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II
COMPLETED · NA
-
Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments
COMPLETED · NA
-
fMRI and Opioid Abstinence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI